Medicine / D-0827-2026
U.S. Food and Drug AdministrationD-0827-2026
Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Illinois, 60047, NDC…
Class I Distributed nationwide or U.S.-wide
Status: Ongoing
What was recalled
Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Illinois, 60047, NDC 65219-594-20.
Recalling firm
Fresenius Kabi USA, LLC
Reason for recall
Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
Where it went
Nationwide in the USA
Shown as U.S. Food and Drug Administration published it (shortened where marked …). Recall Shelf does not change recall facts and is not affiliated with the agency.